Pharma Mar, S.A.
PHMMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $63 | $60 | $150 | $113 |
| Short-Term Investments | $91 | $103 | $33 | $89 |
| Receivables | $35 | $28 | $29 | $79 |
| Inventory | $51 | $39 | $28 | $11 |
| Other Curr. Assets | $7 | $20 | $30 | $28 |
| Total Curr. Assets | $250 | $253 | $275 | $295 |
| Property Plant & Equip (Net) | $59 | $48 | $35 | $31 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $2 | $3 | $3 |
| Long-Term Investments | -$89 | $6 | $17 | -$78 |
| Tax Assets | $36 | $31 | $31 | $28 |
| Other NC Assets | $92 | $2 | $33 | $89 |
| Total NC Assets | $99 | $89 | $118 | $73 |
| Other Assets | $0 | -$1 | $0 | $0 |
| Total Assets | $350 | $341 | $393 | $368 |
| Liabilities | – | – | – | – |
| Payables | $39 | $29 | $27 | $27 |
| Short-Term Debt | $8 | $13 | $13 | $12 |
| Tax Payable | $2 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $26 | $40 |
| Other Curr. Liab. | $31 | $40 | $45 | $36 |
| Total Curr. Liab. | $83 | $96 | $97 | $86 |
| LT Debt | $40 | $27 | $26 | $33 |
| Deferred Rev, NC | $17 | $22 | $45 | $69 |
| Deferred Tax Liab, NC | $0 | $1 | $0 | $0 |
| Other NC Liab. | $0 | $1 | $0 | $0 |
| Total NC Liab. | $59 | $52 | $73 | $104 |
| Other Liabilities | $0 | -$1 | $0 | $0 |
| Cap. Leases | $3 | $4 | $4 | $4 |
| Total Liabilities | $141 | $147 | $170 | $190 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $11 | $11 | $11 | $11 |
| Retained Earnings | $168 | $142 | $157 | $121 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | -$0 |
| Total Equity | $208 | $193 | $223 | $178 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $350 | $341 | $393 | $368 |
| Net Debt | -$15 | -$20 | -$111 | -$68 |